Li, Hai
Chen, Liu-Ying
Zhang, Nan-nan
Li, Shu-Ting
Zeng, Bo
Pavesi, Marco
Amorós, Àlex
Mookerjee, Rajeshwar P
Xia, Qian
Xue, Feng
Ma, Xiong
Hua, Jing
Sheng, Li
Qiu, De-kai
Xie, Qing
Foster, Graham R
Dusheiko, Geoffrey
Moreau, Richard
Gines, Pere
Arroyo, Vicente
Jalan, Rajiv
Article History
Received: 1 December 2015
Accepted: 18 April 2016
First Online: 5 May 2016
Competing interests
: There are potential competing financial interests as follows. Rajiv Jalan received research funding from Vital Therapies, has served on Scientific Advisory Board for Conatus Pharma and received lecture fees from Gambro and has on-going research collaboration with Gambro, Grifols and is the Principal Investigator of an Industry sponsored study (Sequana Medical). He is also inventor for a drug, L-ornithine phenyl acetate which UCL has licensed to Ocera Therapeutics. Vicente Arroyo has research grants from Grifols.